Wells Fargo & Company Adaptive Biotechnologies Corp Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Wells Fargo & Company holds 54,479 shares of ADPT stock, worth $392,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,479
Previous 53,812 1.24%
Holding current value
$392,248
Previous $194,000 43.3%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.37 - $5.12 $2,247 - $3,415
667 Added 1.24%
54,479 $278,000
Q2 2024

Aug 13, 2024
BUY
$2.34 - $3.96 $35,776 - $60,544
15,289 Added 39.69%
53,812 $194,000
Q1 2024

May 10, 2024
BUY
$2.88 - $4.8 $11,937 - $19,896
4,145 Added 12.06%
38,523 $123,000
Q4 2023

Feb 09, 2024
BUY
$3.46 - $5.33 $23,988 - $36,952
6,933 Added 25.26%
34,378 $168,000
Q3 2023

Nov 13, 2023
SELL
$5.07 - $8.44 $113,426 - $188,819
-22,372 Reduced 44.91%
27,445 $149,000
Q2 2023

Aug 15, 2023
BUY
$6.19 - $8.78 $102,425 - $145,282
16,547 Added 49.74%
49,817 $334,000
Q1 2023

May 12, 2023
BUY
$7.8 - $10.11 $71,869 - $93,153
9,214 Added 38.3%
33,270 $293,000
Q4 2022

Feb 13, 2023
SELL
$6.26 - $9.34 $5,108 - $7,621
-816 Reduced 3.28%
24,056 $183,000
Q3 2022

Nov 14, 2022
SELL
$6.5 - $12.67 $65,338 - $127,358
-10,052 Reduced 28.78%
24,872 $178,000
Q2 2022

Aug 12, 2022
SELL
$6.4 - $14.73 $4,345 - $10,001
-679 Reduced 1.91%
34,924 $283,000
Q1 2022

May 16, 2022
BUY
$10.12 - $28.9 $122,330 - $349,343
12,088 Added 51.41%
35,603 $493,000
Q4 2021

Feb 14, 2022
SELL
$25.17 - $36.85 $84,973 - $124,405
-3,376 Reduced 12.55%
23,515 $660,000
Q3 2021

Nov 15, 2021
SELL
$30.02 - $39.87 $253,669 - $336,901
-8,450 Reduced 23.91%
26,891 $915,000
Q2 2021

Aug 16, 2021
SELL
$32.22 - $44.59 $25.2 Million - $34.8 Million
-781,117 Reduced 95.67%
35,341 $1.44 Million
Q1 2021

May 13, 2021
SELL
$37.26 - $67.74 $19.4 Million - $35.3 Million
-521,369 Reduced 38.97%
816,458 $32.9 Million
Q4 2020

Feb 09, 2021
BUY
$45.01 - $65.47 $10.6 Million - $15.4 Million
234,854 Added 21.29%
1,337,827 $79.1 Million
Q3 2020

Nov 05, 2020
BUY
$35.79 - $48.81 $6.86 Million - $9.36 Million
191,746 Added 21.04%
1,102,973 $53.6 Million
Q2 2020

Aug 13, 2020
BUY
$24.95 - $48.38 $656,010 - $1.27 Million
26,293 Added 2.97%
911,227 $44.1 Million
Q1 2020

May 14, 2020
BUY
$16.96 - $34.16 $15 Million - $30.2 Million
884,934 New
884,934 $24.6 Million

Others Institutions Holding ADPT

# of Institutions
204
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.03B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email